$1.470
+0.010 (+0.68%)At close
AMS News
AMS Events
JPMorgan Downgrades ams OSRAM to Underweight, Price Target Cut to CHF 5.35
JPMorgan analyst Craig McDowell downgraded ams OSRAM to Underweight from Neutral with a price target of CHF 5.35, down from CHF 8.90. The firm sees risk to the company's margins in 2026 amid a period of uncertainty.
American Shared Hospital Announces Q3 EPS of 0c Compared to (3c) Last Year
Reports Q3 revenue $7.2M vs $6.999M last year. Gary Delanois, Chief Executive Officer, commented: "I am pleased to report revenue increases in both our three and nine-month results which were primarily driven by increased revenue in our direct patient care services segment as our new physicians in Rhode Island ramp up and volumes increase. Our new radiation therapy center in Puebla Mexico is off to a fantastic start where revenue has grown significantly. I am also gratified to see the period over period increase in Gamma Knife revenue in the third quarter, and we remain vigilant in driving the overall revenue growth of the Company. As we look into the remainder of this year and 2026, we expect further growth in revenue from the new Esprit being installed in our new Gamma Knife center in Guadalajara, Mexico that is expected to startup in the second quarter of 2026. We are also very pleased to announce the recent signing of an Existing Health System to a 10 Year Extension for an Esprit - the latest model Gamma Knife System."
American Shared Hospital reports Q2 EPS (4c) vs. 55c last year
Reports Q2 revenue $7.07M vs. $7.06M last year. Gary Delanois, Chief Executive Officer commented, "I am pleased to see patient volumes increased compared to last quarter and we remain laser focused on expanding our business model and operational enhancements to further position us for robust long-term growth. As we look into the second half of this year, we expect further long-term growth from the new Esprit being installed in Guadalajara, Mexico that is expected to startup in late 2025. Additionally, our recent Certificate of Need approvals for the first radiation therapy treatment center in Bristol, Rhode Island and a proton beam radiation therapy treatment center in Johnston, Rhode Island, also put us on track to further expand our Rhode Island footprint and growth potential. As we stay focused on targeted strategic initiatives to further improve efficiency and to take advantage of economies of scale to maximize profitability, our new business development pipeline, and strong balance sheet strengthens our position for our next phase of growth."
American Shared Hospital reports Q1 EPS (10c) vs 2c last year
Reports Q1 revenue $6.112M vs $5.216M last year. Ray Stachowiak, Executive Chairman of American Shared Hospital Services, stated: "Our first quarter of 2025 was highlighted by double digit revenue growth stemming from the strength of our business model while mitigating lower treatment volumes and some seasonality. Additionally, I am happy to report that we have already begun to see an increase in treatment volumes in April and expect to see further recovery into the back half of this year. Our long-term vision remains strong, and we are on a path of sustained success."
American Shared Hospital appoints Gary Delanois as CEO
Gary Delanois, Chief Executive Officer, added: "Our growth strategy is delivering tangible results, and we are excited about the momentum we are building. We are rapidly evolving beyond our traditional leasing model to a direct provider of radiation therapy treatment services to cancer patients. This transition aligns with our long-term strategy of revenue growth through increased patient volumes rather than equipment utilization. With an expanded business model, increased patient volumes, and operational enhancements, we are positioned for sustainable long-term growth. We are also continuing to implement targeted strategic initiatives to improve efficiency and maximize profitability across our expanding network. Our strong business development pipeline, financial stability, and commitment to innovation ensure that we are well-prepared for the next phase of our growth."
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。